Skip to content
CancerIndex

Ranking · Unmet Need

Trial Gap Index

Burden percentile minus active-trial percentile within the same scope. Positive values flag cancers with high mortality burden but comparatively few active trials. A quantitative signal, not an accusation (CLAUDE.md §324). Caveat (Phase 1): trial counts aggregate a cancer and its NCIt descendants only; registrations phrased at a broader level (e.g. "colorectal cancer" for colon and rectal cancer) are attributed to the broader entity, which can overstate the gap of narrower top-level sites.

Computedci-trial-gap-v1unit: percentile pointshigher = worseAll metrics

Top 15 by Trial Gap IndexMalignant Colon Neoplasm+56.7Malignant Bladder Neoplasm+23.3Cutaneous Melanoma+20Malignant Laryngeal Neoplasm+20Malignant Pancreatic Neoplasm+10Malignant Vaginal Neoplasm+10Malignant Vulvar Neoplasm+10Malignant Kidney Neoplasm+3.3Malignant Mesothelioma+3.3Malignant Ovarian Neoplasm+3.3Malignant Esophageal Neoplasm0Malignant Lung Neoplasm0Malignant Prostate Neoplasm0Malignant Rectal Neoplasm0Malignant Salivary Gland Neop…0
RankΔCancerTrial Gap Index (percentile points)PercentileConfidenceSourcesWhy #n?
1=Malignant Colon Neoplasm+56.7100Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
42471
formula
percentile(mortality_count) − percentile(active_trials)
activity
225
burdenPercentile
96.7
activityPercentile
40

ranking row 2597449

2=Malignant Bladder Neoplasm+23.396.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
14201
formula
percentile(mortality_count) − percentile(active_trials)
activity
346
burdenPercentile
70
activityPercentile
46.7

ranking row 2597450

3=Cutaneous Melanoma+2093.3Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
9199
formula
percentile(mortality_count) − percentile(active_trials)
activity
78
burdenPercentile
46.7
activityPercentile
26.7

ranking row 2597451

4=Malignant Laryngeal Neoplasm+2090Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
3630
formula
percentile(mortality_count) − percentile(active_trials)
activity
66
burdenPercentile
40
activityPercentile
20

ranking row 2597452

5=Malignant Pancreatic Neoplasm+1086.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
35628
formula
percentile(mortality_count) − percentile(active_trials)
activity
904
burdenPercentile
90
activityPercentile
80

ranking row 2597453

5=Malignant Vaginal Neoplasm+1086.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
398
formula
percentile(mortality_count) − percentile(active_trials)
activity
31
burdenPercentile
10
activityPercentile
0

ranking row 2597454

5=Malignant Vulvar Neoplasm+1086.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
946
formula
percentile(mortality_count) − percentile(active_trials)
activity
54
burdenPercentile
23.3
activityPercentile
13.3

ranking row 2597455

8=Malignant Kidney Neoplasm+3.376.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
12995
formula
percentile(mortality_count) − percentile(active_trials)
activity
453
burdenPercentile
60
activityPercentile
56.7

ranking row 2597457

8=Malignant Mesothelioma+3.376.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
2606
formula
percentile(mortality_count) − percentile(active_trials)
activity
96
burdenPercentile
33.3
activityPercentile
30

ranking row 2597456

8=Malignant Ovarian Neoplasm+3.376.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
14436
formula
percentile(mortality_count) − percentile(active_trials)
activity
684
burdenPercentile
73.3
activityPercentile
70

ranking row 2597458

11=Malignant Esophageal Neoplasm066.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
13908
formula
percentile(mortality_count) − percentile(active_trials)
activity
518
burdenPercentile
63.3
activityPercentile
63.3

ranking row 2597459

11=Malignant Lung Neoplasm066.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
158081
formula
percentile(mortality_count) − percentile(active_trials)
activity
2644
burdenPercentile
100
activityPercentile
100

ranking row 2597460

11=Malignant Prostate Neoplasm066.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
28088
formula
percentile(mortality_count) − percentile(active_trials)
activity
1375
burdenPercentile
86.7
activityPercentile
86.7

ranking row 2597462

11=Malignant Rectal Neoplasm066.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
9377
formula
percentile(mortality_count) − percentile(active_trials)
activity
386
burdenPercentile
50
activityPercentile
50

ranking row 2597464

11=Malignant Salivary Gland Neoplasm066.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
795
formula
percentile(mortality_count) − percentile(active_trials)
activity
63
burdenPercentile
16.7
activityPercentile
16.7

ranking row 2597461

11=Malignant Testicular Neoplasm066.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
376
formula
percentile(mortality_count) − percentile(active_trials)
activity
43
burdenPercentile
6.7
activityPercentile
6.7

ranking row 2597463

17=Malignant Thyroid Gland Neoplasm-3.346.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
1707
formula
percentile(mortality_count) − percentile(active_trials)
activity
176
burdenPercentile
30
activityPercentile
33.3

ranking row 2597465

18=Malignant Anal Neoplasm-3.343.3Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
818
formula
percentile(mortality_count) − percentile(active_trials)
activity
68
burdenPercentile
20
activityPercentile
23.3

ranking row 2597466

19=Malignant Breast Neoplasm-3.440Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
41076
formula
percentile(mortality_count) − percentile(active_trials)
activity
2627
burdenPercentile
93.3
activityPercentile
96.7

ranking row 2597467

20=Malignant Liver Neoplasm-6.636.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
19352
formula
percentile(mortality_count) − percentile(active_trials)
activity
906
burdenPercentile
76.7
activityPercentile
83.3

ranking row 2597468

21=Malignant Hypopharyngeal Neoplasm-6.733.3Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
279
formula
percentile(mortality_count) − percentile(active_trials)
activity
53
burdenPercentile
3.3
activityPercentile
10

ranking row 2597469

21=Malignant Penile Neoplasm-6.733.3Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
234
formula
percentile(mortality_count) − percentile(active_trials)
activity
43
burdenPercentile
0
activityPercentile
6.7

ranking row 2597470

23=Leukemia-6.726.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
22688
formula
percentile(mortality_count) − percentile(active_trials)
activity
1769
burdenPercentile
83.3
activityPercentile
90

ranking row 2597471

24=Malignant Central Nervous System Neoplasm-1023.3Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
14176
formula
percentile(mortality_count) − percentile(active_trials)
activity
823
burdenPercentile
66.7
activityPercentile
76.7

ranking row 2597472

24=Malignant Gastric Neoplasm-1023.3Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
11184
formula
percentile(mortality_count) − percentile(active_trials)
activity
652
burdenPercentile
56.7
activityPercentile
66.7

ranking row 2597473

26=Hodgkin Lymphoma-1016.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
1250
formula
percentile(mortality_count) − percentile(active_trials)
activity
179
burdenPercentile
26.7
activityPercentile
36.7

ranking row 2597474

27=Non-Hodgkin Lymphoma-13.313.3Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
20389
formula
percentile(mortality_count) − percentile(active_trials)
activity
2168
burdenPercentile
80
activityPercentile
93.3

ranking row 2597475

28=Malignant Uterine Corpus Neoplasm-16.610Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
3333
formula
percentile(mortality_count) − percentile(active_trials)
activity
411
burdenPercentile
36.7
activityPercentile
53.3

ranking row 2597476

29=Malignant Cervical Neoplasm-16.76.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
3909
formula
percentile(mortality_count) − percentile(active_trials)
activity
505
burdenPercentile
43.3
activityPercentile
60

ranking row 2597477

30=Multiple Myeloma-203.3Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
10690
formula
percentile(mortality_count) − percentile(active_trials)
activity
814
burdenPercentile
53.3
activityPercentile
73.3

ranking row 2597478

31=Malignant Nasopharyngeal Neoplasm-300Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
662
formula
percentile(mortality_count) − percentile(active_trials)
activity
261
burdenPercentile
13.3
activityPercentile
43.3

ranking row 2597479

Data updated 16 hours agoSource updated unknown31 eligible entities · inputs hash d6bcbbcb4081614211290122